12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article reports on the movement of health care stocks in Tuesday's after-market session, highlighting both gainers and losers based on their Q1 earnings reports. Arcutis Biotherapeutics, BioAtla, OptimizeRx, Psyence Biomedical, Bone Biologics, and SINTX Techs saw gains, while Bolt Biotherapeutics, Vivos Therapeutics, Iridex, Prestige Consumer, Akili, and Ocean Biomedical experienced declines.
May 14, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bolt Biotherapeutics stock dropped 15.9% to $1.11, with a market cap of $42.3 million, potentially due to disappointing Q1 results.
Negative earnings reports or failing to meet market expectations often result in stock price declines.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Iridex shares dropped 12.0% to $2.71 after announcing Q1 earnings, with a market cap of $44.0 million.
A decline in stock price post-earnings suggests the results did not meet investor expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Vivos Therapeutics stock fell 12.86% to $2.17 following their Q1 earnings release, with a market cap of $6.4 million.
Stocks typically decline when earnings reports are below market expectations, indicating potential issues.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Arcutis Biotherapeutics stock rose 16.4% after announcing Q1 earnings, with a market cap of $1.0 billion.
Positive earnings reports typically lead to an increase in stock price due to investor optimism.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
BioAtla's stock increased by 13.02% to $2.95 following their Q1 earnings report, with a market cap of $141.9 million.
Stocks often rise following positive earnings reports as they indicate company growth or profitability.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
OptimizeRx stock went up by 7.55% to $11.25 after the Q1 earnings announcement, with a market cap of $204.5 million.
Earnings reports that exceed market expectations can lead to a positive stock price reaction.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90